Structured Review

Bristol Myers amphotericin b deoxycholate
Amphotericin B Deoxycholate, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 89/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amphotericin b deoxycholate/product/Bristol Myers
Average 89 stars, based on 25 article reviews
Price from $9.99 to $1999.99
amphotericin b deoxycholate - by Bioz Stars, 2020-11
89/100 stars

Images

Related Articles

other:

Article Title: Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
Article Snippet: Amphotericin B deoxycholate (Fungizone, Bristol-Myers Squibb, Princeton, New Jersey, USA) was infused intravenously over 4 hours at a daily dose of 0.5 to 1.5 mg/kg of body weight until defervescence and recovery from neutropenia (ANC > 500/mm3 for at least 3 consecutive days).

Article Title: Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
Article Snippet: Efficacy In the analysis of the primary endpoint, 47.9% of the patients who received intravenous itraconazole and 43.8% of the patients who received amphotericin B deoxycholate had a favorable overall response (difference, +4.1 [95% CI, -15.8 to +24.0]) ( ); thus, intravenous itraconazole fulfilled the statistical criteria for non-inferiority to amphotericin B deoxycholate.

Article Title: Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
Article Snippet: Thus, a 95 percent confidence interval for the difference in response rates, within 25 percentage points in either direction, was required for intravenous itraconazole to be considered not inferior to amphotericin B deoxycholate.

Article Title: Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
Article Snippet: Infusionrelated adverse events, nephrotoxicity and hypokalemia occurred much more frequently and with greater severity in those patients who received amphotericin B deoxycholate than in those patients who received itraconazole.

Article Title: Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
Article Snippet: Four patients treated with itraconazole and two patients treated with amphotericin B deoxycholate had breakthrough fungal infections, and all of these were considered as either probable or proven IFI.

Article Title: Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
Article Snippet: Such toxic events have been reported less frequently, but they were not eliminated, even when lipid-based formulations of amphotericin B deoxycholate were used , , , .

In Vitro:

Article Title: Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations
Article Snippet: .. Our results confirm those of several previous investigations which found that liposomal amphotericin B is less active in vitro against C. albicans than is amphotericin B deoxycholate ( , ). .. However, an earlier investigation showed that liposomal amphotericin B and free amphotericin B had comparable in vitro fungistatic and fungicidal activities against Aspergillus spp., Candida spp., Fusarium spp., and C. neoformans ( ).

Article Title: Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations
Article Snippet: .. The two preparations of nystatin were more active in vitro than liposomal amphotericin B against the 10 species tested but less active than ABLC or amphotericin B deoxycholate against 9 of the species tested. .. In the case of A. flavus , both forms of nystatin were as active as ABLC but less active than amphotericin B deoxycholate.

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Bristol Myers compounds amphotericin b deoxycholate
    Damage of A. fumigatus hyphae induced by antifungal agents and human NK cells alone or in combination. Fungal damage was assessed by means of the XTT assay. Shown are the means ± standard errors of the means (SEMs) from at least 3 independent experiments. AmB-D, <t>amphotericin</t> B <t>deoxycholate;</t> LAMB, liposomal amphotericin B; NK, natural killer cell; *, P
    Compounds Amphotericin B Deoxycholate, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compounds amphotericin b deoxycholate/product/Bristol Myers
    Average 93 stars, based on 26 article reviews
    Price from $9.99 to $1999.99
    compounds amphotericin b deoxycholate - by Bioz Stars, 2020-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    Damage of A. fumigatus hyphae induced by antifungal agents and human NK cells alone or in combination. Fungal damage was assessed by means of the XTT assay. Shown are the means ± standard errors of the means (SEMs) from at least 3 independent experiments. AmB-D, amphotericin B deoxycholate; LAMB, liposomal amphotericin B; NK, natural killer cell; *, P

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells

    doi: 10.1128/AAC.01993-18

    Figure Lengend Snippet: Damage of A. fumigatus hyphae induced by antifungal agents and human NK cells alone or in combination. Fungal damage was assessed by means of the XTT assay. Shown are the means ± standard errors of the means (SEMs) from at least 3 independent experiments. AmB-D, amphotericin B deoxycholate; LAMB, liposomal amphotericin B; NK, natural killer cell; *, P

    Article Snippet: The antifungal compounds amphotericin B deoxycholate (Bristol-Myer Squibb, Munich, Germany), LAMB (Gilead Sciences, San Dimas, CA, USA), voriconazole (Pfizer, Groton, CT, USA), and caspofungin and posaconazole (MSD/Merck, Kenilworth, NJ, USA) were commercially obtained.

    Techniques: XTT Assay

    Effect of antifungal agents on the viability of human NK cells. Apoptosis and necrosis were assessed by means of annexin V and propidium iodide (PI) staining. Shown are the means and SEMs from at least 3 different experiments. AmB-D, amphotericin B deoxycholate; LAMB, liposomal amphotericin B; * , P

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells

    doi: 10.1128/AAC.01993-18

    Figure Lengend Snippet: Effect of antifungal agents on the viability of human NK cells. Apoptosis and necrosis were assessed by means of annexin V and propidium iodide (PI) staining. Shown are the means and SEMs from at least 3 different experiments. AmB-D, amphotericin B deoxycholate; LAMB, liposomal amphotericin B; * , P

    Article Snippet: The antifungal compounds amphotericin B deoxycholate (Bristol-Myer Squibb, Munich, Germany), LAMB (Gilead Sciences, San Dimas, CA, USA), voriconazole (Pfizer, Groton, CT, USA), and caspofungin and posaconazole (MSD/Merck, Kenilworth, NJ, USA) were commercially obtained.

    Techniques: Staining